Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutamate Receptor”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Early research (Phase 1)Study completedNCT00538798
What this trial is testing

PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

Who this might be right for
HealthyGlutamate ReceptormGlur5 Protein+3 more
National Institute of Mental Health (NIMH) 50
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT02230592
What this trial is testing

PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX

Who this might be right for
Anxiety DisorderMajor Depressive Disorder
National Institute of Mental Health (NIMH) 19
Testing effectiveness (Phase 2)Study completedNCT00001365
What this trial is testing

Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System

Who this might be right for
Neurodegenerative DiseaseParkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 42
Testing effectiveness (Phase 2)Ended earlyNCT04821271
What this trial is testing

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

Who this might be right for
Major Depressive DisorderTreatment-Resistant DepressionDepression
National Institute of Mental Health (NIMH) 11
Not applicableStudy completedNCT02456168
What this trial is testing

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Northwell Health 30
Early research (Phase 1)Study completedNCT01896843
What this trial is testing

Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain

Who this might be right for
mGluR5 Receptors
National Institute of Mental Health (NIMH) 19
Large-scale testing (Phase 3)Study completedNCT04039022
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant DepressionDepression
Axsome Therapeutics, Inc. 876
Not applicableEnded earlyNCT00951314
What this trial is testing

Brain Glutamate Receptors and Cocaine Dependence

Who this might be right for
Drug AbuseCocaine Dependence
National Institute on Drug Abuse (NIDA) 30
Testing effectiveness (Phase 2)Study completedNCT01882829
What this trial is testing

Nuedexta in Treatment-Resistant Major Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant
James Murrough 20
Early research (Phase 1)Study completedNCT06273540
What this trial is testing

Phase1, STP7 Cocaine Drug-Drug Interaction Study

Who this might be right for
Cocaine Use Disorder
Stalicla SA 21
Post-approval studies (Phase 4)Study completedNCT00688324
What this trial is testing

Biomarker Study of Acamprosate in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Maryland, Baltimore 36
Post-approval studies (Phase 4)Study completedNCT01108029
What this trial is testing

Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Who this might be right for
Parkinson's DiseaseGait Disorders, Neurologic
University Hospital, Lille 28
Early research (Phase 1)Study completedNCT02769936
What this trial is testing

Glutamate, Learning, and Working Memory

Who this might be right for
Schizophrenia
University of California, Los Angeles 110
Not applicableStudy completedNCT00042523
What this trial is testing

Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 61
Early research (Phase 1)Ended earlyNCT02108015
What this trial is testing

Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8

Who this might be right for
Healthy Volunteers
National Institute of Mental Health (NIMH) 6
Not applicableStudy completedNCT02236897
What this trial is testing

PET Imaging in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Johns Hopkins University 36
Early research (Phase 1)Ended earlyNCT04618263
What this trial is testing

Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers

Who this might be right for
Major Depressive DisorderExcessive Sleepiness
Syndeio Biosciences, Inc 18
Not applicableUnknownNCT00317668
What this trial is testing

Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

Who this might be right for
Epilepsy
Hadassah Medical Organization 250
Early research (Phase 1)Study completedNCT01548703
What this trial is testing

A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers

Who this might be right for
Healthy
BrainCells Inc. 30
Load More Results